首页> 美国政府科技报告 >In vivo Modulation with Anti-Interleukin-1 (IL-1) Receptor (p80) Antibody 35F5 ofthe Response to IL-1. The Relationship of Radioprotection, Colony-Stimulating Factor, and IL-6
【24h】

In vivo Modulation with Anti-Interleukin-1 (IL-1) Receptor (p80) Antibody 35F5 ofthe Response to IL-1. The Relationship of Radioprotection, Colony-Stimulating Factor, and IL-6

机译:用IL-1反应的抗白细胞介素-1(IL-1)受体(p80)抗体35F5的体内调节。辐射防护,集落刺激因子和IL-6的关系

获取原文

摘要

Interleukin-1 (IL-1) is radioprotective and induces both circulating colony-stimulating factor(s) (CSF) and IL-6 in mice. We evaluated the relationship among these three responses to IL-1 using anti-IL 1 receptor antibody 35F5. This antibody in vitro blocks responses of T cells and fibroblasts, but not of B cells or myeloid cell lines, to IL-1. Administration of 35F5 alone before irradiation reduced the number of surviving mice compared with those not treated with 35F5, demonstrating that endogenous IL-1 participates in the natural resistance to radiation. Thirty micrograms of 35F5 per mouse also reduced by 92% the survival of irradiated mice pretreated with 0.3 micrograms of IL01. Similarly, 30 micrograms of 35F5 reduced by 96% to 98% the induction of IL-6 by IL-1. In contrast, 30 micrograms of 35F5 resulted in only moderate reduction of circulating CSF. Consequently, the level of circulating CSF after 35F5 treatment was still equivalent to levels of CSF that were induced by doses of IL-1 in the radioprotective range. Keywords: Reprints (js)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号